BLOG 

Cardiovascular Clinical Research

Discover the latest updates on cardiovascular clinical research, innovative studies, and exciting conference news. Join us on our journey as we explore the latest discoveries and innovations transforming how we understand and treat cardiovascular diseases.

  • All
  • Careers
  • Fairs
  • Insights
Oxford University historic buildings and bicycles
Insights

Celebrating Success: Imbria Pharmaceuticals’ Phase 2 IMPROVE-HCM Trial Results

We are thrilled to convey our heartfelt congratulations to Imbria Pharmaceuticals on the outstanding results from the Phase 2 IMPROVE-HCM clinical trial. The trial, which evaluated ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM), has shown significant improvements in...
A healthcare professional performing an echocardiography examination on a male patient, showcasing the ultrasound probe in use on the patient's chest with the echocardiogram display in the background.
Insights

Echo Core Lab is a Key for Using Echocardiography in Clinical Trials

Echocardiography is a noninvasive method to assess cardiac anatomy, function, and hemodynamics and may provide important data on the effects of a new drug or medical device. In many cardiovascular clinical trials, echocardiography data are used for assessing eligibility and...
A healthcare professional interacts with digital healthcare and finance icons, symbolizing the integration and transition in healthcare management.
Insights

Navigating Change: Navigating a CRO Transition in Cardiovascular Research

The ability to steer through changes and skillfully manage a transition to another Contract Research Organization (CRO) is sometimes essential for progress in the dynamic field of cardiovascular research. CROs are indispensable; they accelerate the translation of innovative cardiovascular therapies...
Comprehensive Approach to Phase 1 Cardiovascular Studies
Insights

Integrating Phase 1 Studies in Healthy Volunteers and Patients with Cardiovascular Disease – A Comprehensive Approach  

Phase 1 clinical studies are the initial step in drug development, designed to assess the safety and tolerability of a new molecule in humans. Traditionally investigational medicinal products (IMP) were tested in multiple Phase 1 clinical trials that enrolled large...
Single researcher analyzing cardiovascular research data on a large monitor in a professional office setting, showing deep concentration and note-taking.
Insights

Site Management and Study Start-Up Enhancement: A Strategic Focus in Cardiovascular Research

Insights into best practices and efficiency improvement in clinical trials highlight the importance of thorough site identification and selection in the field of cardiovascular research. Managing the complex regulatory environment requires well-thought-out document management and early engagement with regulatory authorities....
A detailed overview of cardiovascular clinical trials showcasing the strategic importance of partnering with specialist CROs for enhanced trial efficiency and success.
Insights

Maximizing Success in Cardiovascular Trials: The Advantage of Partnering with a Specialist CRO

The industry spent over $200 billion globally in 2021 on developing new therapies for treating cardiovascular diseases. However, it’s estimated that more than half of the investment in clinical development is wasted. Various factors contribute to this, including a lack...
A Clinical Research Associate monitoring data on a laptop with cardiovascular charts and medical equipment in the background, symbolizing a cardiovascular trial in Europe.
Careers

What is a Clinical Research Associate doing?

Maike, 32, and Nadja, 32, work as Clinical Research Associates (CRA) in medical research. They discuss what makes this job unique and why they enjoy working as CRAs. Maike, how did your day start today? Maike: I returned from Oslo...
Fairs

SCIRENT is excited to participate at the TCT Conference 2023 in San Francisco

SCIRENT is excited to participate at the TCT Conference from October 23-26, 2023, in San Francisco. The Transcatheter Cardiovascular Therapeutics (TCT) conference, hosted by the Cardiovascular Research Foundation (CRF), is the world's premier educational forum for interventional cardiovascular medicine. For...
heart surgery
Insights

First patient enrolled in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

Roswell, Georgia – 9 October, 2023 – Roivios Ltd., a medical device company pioneering a revolutionary treatment to reduce poor surgical outcomes associated with Acute Kidney Injury(AKI), today announces the first patient has been enrolled in the BIPASS-AKI early feasibilitystudy...
Come and be a part of Amsterdam ESC 2023, where you can witness groundbreaking developments in cardiovascular treatment. Collaborate with the most prominent professionals in the industry, delve into state-of-the-art abstracts, and unleash innovative possibilities for your patients. This is an unmissable chance to forge connections with Europe's leading cardiovascular CRO as well - let us work together towards achieving better health outcomes!
Fairs

Join SCIRENT at ESC Congress 2023

SCIRENT will be participating in the renowned ESC Congress in Amsterdam from 25th to 28th August 2023. This prestigious event is a powerful platform for us as it brings together leading experts from the field of cardiology to shape the...
ESC Heart Failure 2023
Fairs

Join Us in Prague for the ESC Heart Failure Meeting

Save the dates in your agenda and join us in Prague from 20 to 23 May 2023 for the ESC Heart Failure Association (HFA) annual meeting bringing together scientists, healthcare professionals, and other players from around the world. The world's leading...
CSI Frankfurt 2023 is one of the world's leading clinical research organizations, dedicated to advancing new treatments for cardiovascular diseases. We need your help to make this trial a success. Read our blog to learn more about the trial and how you can be part of it. Join us in our mission to save lives and make a difference!
Fairs

Conferences in Cardiovascular Clinical Research 2023

SCIRENT is thrilled to announce that we will be attending several high-ranking cardiovascular conferences in 2023.  Meet our team to discover how SCIRENT, a specialized cardiovascular research organization, can help your business develop innovative therapies. Our competence in clinical research...
Fairs

Connect with Us at HFSA Annual Scientific Meeting 2022

SCIRENT, a full-service contract research organization (CRO) specializing in cardiovascular trials, is joining forces with CCS, a US-based cardiovascular clinical research organization, at HFSA Annual Scientific Meeting 2022 in Washington. Come and meet us at booth 228 from September 30, 2022 -...
Fairs

Meet Us at ESC Congress 2022 in Barcelona

SCIRENT is excited to participate at the ESC Congress 2022 in Barcelona, which is taking place from 26-29 August 2022. Please book an appointment with our leadership to learn more about our industry-leading cardiovascular research services and patient recruitment capabilities....
SCIRENT is exhibitor at the American Heart Association 2021 Scientific Sessions.
Fairs

Meet Us at AHA 2021

10.11.2021. SCIRENT is attending the American Heart Association’s Scientific Sessions, AHA 2021, from November 13-15, 2021 as a proud exhibitor. Visit our booth and connect with us live to learn more about our industry-leading cardiovascular research services, patient recruitment capabilities,...
Careers

SCIRENT Appoints Dr. Maximilian Posch, MD, as Chief Medical Officer

BERLIN, Sept. 21, 2021 /PRNewswire/ SCIRENT, an international full-service cardiovascular contract research organization (CRO), is proud to appoint Dr. Maximilian Posch as Chief Medical Officer. In his new position, Dr. Posch will be an important driver of SCIRENT's growth by...
Berlin Heals' innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure.
Insights

Innovative Medical Device for Heart Failure Treatment Delivers Promising Results

Berlin Heals' innovative implantable C-MIC device has demonstrated encouraging clinical results in the treatment of heart failure. They are now published in ESC Heart Failure. The C-MIC is a small implantable device that delivers a minimal constant electrical microcurrent to...
Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials during the COVID-19 pandemic
Insights

Restarting by Design: Agile Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials

The entire landscape of hospital-based clinical trials dramatically changed when COVID-19 singlehandedly stopped the global recruitment of ongoing cardiovascular trials. Heart failure clinical trials were already subject to factors such as regional variation in clinical practice, trial implementation, and patient...
SCIRENT Virtual Core Lab
Insights

SCIRENT and Virtonomy Announce Joint Efforts to Advance Use of Virtual Patients in Medical Device Clinical Trials

SCIRENT, a full-service contract research organization (CRO) specialized in cardiovascular trials, and Virtonomy, a pioneer in developing data-driven clinical trials using virtual patients, announced today their cooperation on the use of virtual patients in medical device clinical trials. Both companies offer...
Human Heart Illustration
Insights

An Innovative Approach in Treating Heart Failure

Global medical technology and innovation company, LivaNova PLC, conducts the large medical device study ANTHEM-HFrEF to evaluate whether autonomic regulation therapy will benefit patients with symptomatic heart failure and reduced ejection fraction. The trial is performed by the US-based CRO...
A healthcare professional performing an echocardiography examination on a male patient, showcasing the ultrasound probe in use on the patient's chest with the echocardiogram display in the background.

Echo Core Lab is a Key for Using Echocardiography in Clinical Trials

Echocardiography is an indispensable tool in clinical trials, providing detailed insights into cardiac function and structure without invasive procedures. Echo Core Labs enhance the precision and reliability of these measurements by standardizing procedures across multiple trial sites, significantly reducing variability and improving data quality. This critical role not only supports better clinical outcomes but also ensures the accuracy necessary for developing new medical treatments.

Weiterlesen »
A healthcare professional interacts with digital healthcare and finance icons, symbolizing the integration and transition in healthcare management.

Navigating Change: Navigating a CRO Transition in Cardiovascular Research

In the rapidly evolving landscape of cardiovascular research, the strategic transition between Contract Research Organizations (CROs) is critical. This excerpt delves into the nuances of CRO transitions, highlighting the importance of meticulous planning, transparent communication, and the agility to adapt to new challenges. Understand the pivotal role that CROs play in advancing therapeutic innovations from concept to clinical reality, and explore the strategies that ensure these transitions strengthen, rather than hinder, the research continuum.

Weiterlesen »
Comprehensive Approach to Phase 1 Cardiovascular Studies

Integrating Phase 1 Studies in Healthy Volunteers and Patients with Cardiovascular Disease – A Comprehensive Approach  

Phase 1 clinical studies are the initial step in drug development, designed to assess the safety and tolerability of a new molecule in humans. Traditionally investigational medicinal products (IMP) were tested in multiple Phase 1 clinical trials that enrolled large numbers of healthy participants before a first patient was randomized.

Weiterlesen »

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Thank you for your application.

We will get in touch shortly.